STING1 and breast neoplasm: By assessing the induction of IFN‐I response, we found that CS‐5BImi, CS‐5BThi, and CS‐6Ind can effectively upregulate the expression of Ifnβ1, a key marker of cGAS‐STING activation, in 4T1 breast tumor cells (Figure 2c).